| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.43B | $1.37B | $1.31B |
| YoY Revenue Growth % | +4.2% | +4.3% | — |
| Gross Profit | $899.0M | $870.0M | — |
| Gross Margin % | 62.9% | 63.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $160.0M | $196.0M | $263.0M |
| Operating Margin % | 11.2% | 14.3% | 20.0% |
| Net Income (GAAP) | $169.0M | $88.0M | $79.0M |
| EBITDA (Normalized) | $415.2M | $425.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $688.0M | $770.0M | $702.0M |
| Capital Expenditures (CapEx) | $319.0M | $287.0M | — |
| Free Cash Flow (FCF) | $369.0M | $483.0M | $702.0M |
| FCF Margin % | 25.8% | 35.2% | 53.4% |
| Return on Invested Capital (ROIC %) | 0.9% | 1.3% | — |
| Cash & Short-Term Equivalents | $231.0M | $332.0M | — |
| Total Debt (Short + Long Term) | $7.90B | $6.75B | — |
| Total Stockholders' Equity | $5.91B | $5.56B | — |